pmid,title,journal,year,drug,disease
40010631,Risk of postacute sequelae of COVID-19 and oral antivirals in adults aged over 60 years: A nationwide retrospective cohort study.,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,2025,Molnupiravir,Chronic Obstructive Pulmonary Disease
38702925,Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre-existing chronic obstructive pulmonary diseases.,Expert review of anti-infective therapy,2024,Molnupiravir,Chronic Obstructive Pulmonary Disease
38222320,Real-World Effectiveness Study of Nirmatrelvir-Ritonavir or Molnupiravir in Hospitalized Unvaccinated Patients with Chronic Respiratory Diseases and Moderate COVID-19 at Presentation.,International journal of chronic obstructive pulmonary disease,2024,Molnupiravir,Chronic Obstructive Pulmonary Disease
36992319,Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV-2 Infection Managed in Out-Patient Setting.,Viruses,2023,Molnupiravir,Chronic Obstructive Pulmonary Disease
36193938,Confronting antimicrobial resistance together.,American journal of physiology. Lung cellular and molecular physiology,2022,Molnupiravir,Chronic Obstructive Pulmonary Disease
